|
Tamoxifen and raloxifene are selective estrogen receptor modulators that have been shown in randomized controlled trials to reduce the risk of estrogen receptor positive breast cancer stromectol for pinworms Statin use was consistently associated with reduced mortality from BC in IDC patients HR 0 |
|